Authors


Jonathan Hatoun, MD, MPH, MS

Latest:

Identifying Children at Risk of Asthma Exacerbations: Beyond HEDIS

Analysis of insurance claims reveals that criteria other than the Healthcare Effectiveness Data and Information Set (HEDIS) persistent asthma definition can identify more at-risk patients with reasonable loss of specificity.


Avery C. Plough, BA

Latest:

Does Comparing Cesarean Delivery Rates Influence Women’s Choice of Obstetric Hospital?

This randomized controlled trial finds that a hospital cesarean delivery rate comparison tool affects women’s perceptions but not where they choose to deliver.


Joy Li-Yueh Lee, MS

Latest:

A Systematic Review of Reference Pricing: Implications for US Prescription Drug Spending

Reference pricing is an effective cost-containment tool widely used in other countries; it may be an attractive policy strategy for the US healthcare system.


Jennifer N. Goldstein, MD, MSc

Latest:

Low-Cost Insulin for Socially At-Risk Patients: Evidence for Effectiveness

Human synthetic insulin may offer low-cost, effective treatment for certain patients with diabetes and financial constraints.


Felicia McCant, MSSW

Latest:

Evaluation of a Packaging Approach to Improve Cholesterol Medication Adherence

A 7.6% improvement in 12-month cholesterol refill was observed among US military veterans randomized to an adherence blister packaging intervention versus an education-only intervention.




Ya-Fen Chan, PhD

Latest:

Value-Based Payment in Implementing Evidence-Based Care: The Mental Health Integration Program in Washington State

Value-based payment improved fidelity to key elements of the Collaborative Care Model—an evidence-based mental health intervention—and improved patient depression outcomes in Washington state.




Christian Wernz, PhD

Latest:

Computed Tomography Scan Use Variation: Patient, Hospital, and Geographic Factors

We observed small-area variation in computed tomography scan use for inpatients in New York State, even after controlling for relevant patient and hospital characteristics.


Lisa V. Rubenstein, MD, MSPH

Latest:

Early Changes in VA Medical Home Components and Utilization

Significant changes were found in patients' utilization of healthcare related to early implementation of medical home components in VA primary care clinics.


Mary K. Caffrey
Mary K. Caffrey

Latest:

Healthy State: Practicing What They Preach in Louisiana

An IVBM event cohosted by The American Journal of Managed Care focused on Healthy State, a multiyear, multistakeholder commitment to moving Louisiana ahead in America’s Health Rankings.



Renato G. Martins, MD

Latest:

Second-line and Third-line Chemotherapy for Lung Cancer: Use and Cost

Using health insurance claims, we identified common first-, second-, and third-line chemotherapy regimens for patients with lung cancer and associated utilization and costs of care.


M. Christopher Roebuck, PhD

Latest:

The Price of Progress: Understanding Innovation and Affordability of Prescription Drugs

Economic incentives and patent protections drive development of innovative medications. Drug prices are determined by consumer demand, not production costs. Therefore, governmental regulation risks future investment in research and development.




Jo-Anne Rizzotto, MEd, RD, CDE

Latest:

CHAPTER 3. Guideline for Detection and Management of Diabetes in Pregnancy

From the Adult Diabetes and Clinical Research sections, Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts


Felicia Forma, BSc

Latest:

The Cost of Adherence Mismeasurement in Serious Mental Illness: A Claims-Based Analysis

This study demonstrates that common pharmacy claims-based measures underestimate the effect of actual adherence on inpatient costs among patients with serious mental illness.




David H. Au, MD

Latest:

Organizational Structure for Chronic Heart Failure and Chronic Obstructive Pulmonary Disease

In a nationwide cross-sectional comparison of organizational structure for chronic disease management, less attention was given to chronic obstructive pulmonary disease than chronic heart failure.


David Anderson, MSPPM

Latest:

Prospective or Retrospective ACO Attribution Matters for Seriously Ill Patients

This study compared beneficiary characteristics and Medicare per capita expenditures among seriously ill Medicare accountable care organization (ACO) populations defined using prospective and retrospective claims-based attribution methods.


Vincent Mor, PhD

Latest:

Medicare Advantage Control of Postacute Costs: Perspectives From Stakeholders

This qualitative study examines the methods that Medicare Advantage plans use to control or reduce postacute spending and their associated unintended consequences.



B. Ashleigh Guadagnolo, MD, MPH

Latest:

Survival and Cost-Effectiveness of Hospice Care for Metastatic Melanoma Patients

Hospice care is associated with improved median survival time for the patients diagnosed with metastatic melanoma, accompanied by decreased end-of-life costs.


Burgi Riens, DSc

Latest:

Is There a Survival Benefit Within a German Primary Care-Based Disease Management Program?

Patients with type 2 diabetes in a German disease management program had a lower mortality rate after 3 years than those not in the program.


Clarke P. Anderson, MD

Latest:

The Challenge of Palliative Care for Adolescents and Young Adults

End-of-life care for adolescents and young adults requires an approach that addresses the unique developmental and spiritual issues seen in that population.


AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo